ICD-10 Coding for Metastatic Colorectal Cancer(C18.3, C18.9, C18.9B)
Learn about ICD-10 coding for metastatic colorectal cancer, including primary and metastatic site codes, documentation requirements, and coding pitfalls.
Complete code families applicable to Metastatic Colorectal Cancer
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C18.9 | Malignant neoplasm of colon, unspecified | Use when the specific site of the colon cancer is not documented. |
|
| C78.7 | Secondary malignant neoplasm of liver and intrahepatic bile duct | Use when colorectal cancer has metastasized to the liver. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutMetastatic Colorectal Cancer
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Metastatic Colorectal Cancer.
Failing to document metastatic sites
Impact
Clinical: Impacts treatment decisions and prognosis., Regulatory: Non-compliance with coding standards., Financial: Potential loss of reimbursement for metastatic treatment.
Mitigation
Use standardized templates for oncology documentation, Regular training on documentation requirements
Using C18.9 when specific site is known
Impact
Reimbursement: May result in lower DRG payment due to unspecified coding., Compliance: Non-compliance with coding guidelines for specificity., Data Quality: Decreases accuracy of cancer registry data.
Mitigation
Document and code the specific site of the colon cancer.
Specificity of Metastatic Site Documentation
Impact
Risk of audits due to unspecified metastatic sites.
Mitigation
Ensure all metastatic sites are documented with imaging or biopsy confirmation.